Compare DAO & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAO | PRGO |
|---|---|---|
| Founded | 2006 | 1887 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | 2013 |
| Metric | DAO | PRGO |
|---|---|---|
| Price | $15.61 | $10.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 54.0K | ★ 3.7M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $12.24 | N/A |
| Revenue Next Year | $14.60 | $1.02 |
| P/E Ratio | $72.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.30 | $9.23 |
| 52 Week High | $15.65 | $28.39 |
| Indicator | DAO | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 66.25 | 45.18 |
| Support Level | $9.29 | $9.42 |
| Resistance Level | N/A | $11.72 |
| Average True Range (ATR) | 1.12 | 0.51 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 86.27 | 18.82 |
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.